Moreover, direct analysis of prostate disease progression has shown that ERβ expression declines as prostate cancer develops [although expression is regained in lymph node and bone metastasis (Horvath et al. 2001; Ji et al. 2005; Lai et al. 2004; Leav et al. 2001)]. The gene discussed is ESR2; the disease is prostate cancer.